David Mims

David W.
Mims is Chief Executive Officer at Progenics Pharmaceuticals, Inc. since 2019.
He is Director at SouthPoint Bank since 2015 and Director at Guideway Care, Inc. since 2017.
He is a Member of The American Institute of Certified Public Accountants and the Alabama Society of Certified Public Accountants.
Former roles include Director at The University of Alabama from 2000 to 2012, Director at SouthPoint Bancshares, Inc., Senior Accountant at Ernst & Young LLP, Chief Operating Officer & Executive Vice President at Aptalis Pharma Canada ULC, President-US Specialty Pharmaceuticals at Aptalis Pharma LLC in 2011, Chief Operating & Financial Officer at Aptalis Pharma US, Inc. from 1991 to 1998, and Chief Operating Officer & Executive Vice President at Cebert Pharmaceuticals, Inc. from 1998 to 2000.
Education includes undergraduate studies at Auburn University.